PDF-EMA5514792018EMEAHCCoagadexhuman coagulation factor XAn overview

Coagadex contains the active substance human coagulation factor XHow is CoagadexusedCoagadex is given byinjection 30 Churchill PlaceCanary Wharf London E14 5EUUnited KingdomAn agency of the European. Prof . Khaled. . Yassen. MD FFARCSI. Department of . Anaesthesia. Liver Institute, . Menoufiya. University, Egypt.. kyassen61@hotmail.com. Old and New Liver Institute, . Menoufiya. University, Egypt. Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter. 250,000 – 400,000 per microliter . (too few thrombocytopenia – too many thrombocytosis). Lifespan on average 6 – 10 days. Thrombocytes. Platelets (Thrombocytes). 2- 4 micromillimeters in diameter. 250,000 – 400,000 per microliter . (too few thrombocytopenia – too many thrombocytosis). Lifespan on average 6 – 10 days. Guy Young, MD. Children’s Hospital Los Angeles. University of Southern California Keck School of Medicine. Abbreviations. Abbreviations will be explained the first time the term appears on a slide. Sulistyo. . Rini. , . MSc. Five Stages of . Hemostasis. Vessel spasm. Formation of the platelet plug. Blood coagulation or development of an insoluble fibrin . clot. Clot retraction . Clot dissolution . MD. Blood Coagulation Overview and Acquired Hemorrhagic Disorders . Abbreviations. Abbreviations will be explained the first time on the term appears on a slide. Lecture Outline. Primary Hemostasis. Disorders of primary hemostasis. MD. Blood Coagulation Overview and Acquired Hemorrhagic Disorders . Abbreviations. Abbreviations will be explained the first time on the term appears on a slide. Lecture Outline. Primary Hemostasis. Disorders of primary hemostasis. Edin. ). Haemostasis-blood must be maintained in a fluid state in order to function as a transport system, but must be able to solidify to form a clot following vascular injury in order to prevent excessive bleeding, a process known as haemostasis. It is localised to the tissue damage and is followed by removal of the clot and tissue damage.. Mehran Karimi MD. Tehran, September 14, 2017. Agenda. Background. Causes of bleeding and Clinical manifestations. Classification of coagulation disorders in neonates. Primary investigation and diagnostic evaluation. M. AND J. E. WYNANDS, M.D., C.IVI.~ THE V~Y F_~aLY STUVmS of this subject, many controversies existed regard- ing the various factors and mechanisms involved in the dotting process. One simply has to Dr. shatha Sami alyasrri. Assistant professor . Bleeding disorders during pregnancy and . delivery. . A. Inherited . Vascular abnormalities. Platelet disorders. Coagulation disorders. B.Acquired. Thrombocytopenia. Professor . Dr.Noori. Mohammed . Luaibi. HEMOSTASIS EVENTS . The . term hemostasis means prevention of blood loss. Whenever a vessel is severed or ruptured, hemostasis is achieved by several mechanisms: (. and . congestion. both. . refer. to an . increase. in . blood. volume . within. a . tissue. , . but. . have. . different. . underlying. . mechanisms. .. Hyperemia. . is. . an. . active. . Nervana. . Bayoumy. . Associate . Professor. Department of Physiology. . Objectives. At the end of this lecture . you . should be able to:. Recognize the different clotting factors. U. nderstand the role of calcium ions during clotting cascades..